Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toni Ibrahim

Showing results (61-70 of 223) with videos related to

Pageof 23
Sort By:
Clinical Breast Cancer|July 19, 2011
Role of RANK, RANKL, OPG, and CXCR4 tissue markers in predicting bone metastases in breast cancer patientsToni Ibrahim, Emanuele Sacanna, Michele Gaudio, et al.
Oncotargets and Therapy|October 28, 2016
Current classification, treatment options, and new perspectives in the management of adipocytic sarcomasAlessandro De Vita, Laura Mercatali, Federica Recine, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 27, 2015
Feasibility and utility of re-treatment with (177)Lu-DOTATATE in GEP-NENs relapsed after treatment with (90)Y-DOTATOCStefano Severi, Maddalena Sansovini, Annarita Ianniello, et al.
Journal of Clinical Medicine|August 10, 2024
Denosumab Re-Challenge and Long-Term Efficacy for Aneurysmal Bone Cyst of the Spine: Enhanced Treatment AlgorithmGisberto Evangelisti, Franziska C S Altorfer, Luigi Falzetti, et al.
Medicine|May 20, 2021
ALK-negative lung inflammatory myofibroblastic tumor in a young adult: A case report and literature review of molecular alterationsSilvia Angela Debonis, Alberto Bongiovanni, Federica Pieri, et al.
Cancer Chemotherapy and Pharmacology|August 21, 2009
A phase IB dose-finding trial of liposomal doxorubicin in combination with capecitabine in patients with pretreated metastatic breast cancerAndrea Rocca, Roberta Maltoni, Alessandro Passardi, et al.
Oncotargets and Therapy|December 15, 2015
First-line chemotherapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinomaAlberto Bongiovanni, Nada Riva, Marianna Ricci, et al.
Panminerva Medica|September 21, 2020
CAR T cells targeting options in the fight against multiple myelomaFabio Nicolini, Sara Bravaccini, Massimiliano Mazza, et al.
International Journal of Oncology|April 15, 2011
Bone metastases detection by circulating biomarkers: OPG and RANK-LLaura Mercatali, Toni Ibrahim, Emanuele Sacanna, et al.
International Journal of Molecular Sciences|August 1, 2017
Tumor-Stroma Crosstalk in Bone Tissue: The Osteoclastogenic Potential of a Breast Cancer Cell Line in a Co-Culture System and the Role of EGFR InhibitionLaura Mercatali, Federico La Manna, Giacomo Miserocchi, et al.
Pageof 23

Showing results (61-70 of 223) with videos related to

Sort By:
Pageof 23
Clinical Breast Cancer|July 19, 2011
Role of RANK, RANKL, OPG, and CXCR4 tissue markers in predicting bone metastases in breast cancer patientsToni Ibrahim, Emanuele Sacanna, Michele Gaudio, et al.
Oncotargets and Therapy|October 28, 2016
Current classification, treatment options, and new perspectives in the management of adipocytic sarcomasAlessandro De Vita, Laura Mercatali, Federica Recine, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 27, 2015
Feasibility and utility of re-treatment with (177)Lu-DOTATATE in GEP-NENs relapsed after treatment with (90)Y-DOTATOCStefano Severi, Maddalena Sansovini, Annarita Ianniello, et al.
Journal of Clinical Medicine|August 10, 2024
Denosumab Re-Challenge and Long-Term Efficacy for Aneurysmal Bone Cyst of the Spine: Enhanced Treatment AlgorithmGisberto Evangelisti, Franziska C S Altorfer, Luigi Falzetti, et al.
Medicine|May 20, 2021
ALK-negative lung inflammatory myofibroblastic tumor in a young adult: A case report and literature review of molecular alterationsSilvia Angela Debonis, Alberto Bongiovanni, Federica Pieri, et al.
Cancer Chemotherapy and Pharmacology|August 21, 2009
A phase IB dose-finding trial of liposomal doxorubicin in combination with capecitabine in patients with pretreated metastatic breast cancerAndrea Rocca, Roberta Maltoni, Alessandro Passardi, et al.
Oncotargets and Therapy|December 15, 2015
First-line chemotherapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinomaAlberto Bongiovanni, Nada Riva, Marianna Ricci, et al.
Panminerva Medica|September 21, 2020
CAR T cells targeting options in the fight against multiple myelomaFabio Nicolini, Sara Bravaccini, Massimiliano Mazza, et al.
International Journal of Oncology|April 15, 2011
Bone metastases detection by circulating biomarkers: OPG and RANK-LLaura Mercatali, Toni Ibrahim, Emanuele Sacanna, et al.
International Journal of Molecular Sciences|August 1, 2017
Tumor-Stroma Crosstalk in Bone Tissue: The Osteoclastogenic Potential of a Breast Cancer Cell Line in a Co-Culture System and the Role of EGFR InhibitionLaura Mercatali, Federico La Manna, Giacomo Miserocchi, et al.
Pageof 23